Back
Envela Corp. 10K Form
Buy
96
ELA
Envela Corp.
Last Price:
$13.23
Seasonality Move:
18.09%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2021-03-23 | 10K | ELA/Envela Corp. Annual |
| 2020-11-10 | 10Q | ELA/Envela Corp. Quarterly |
| 2020-11-05 | 10Q | ELA/Envela Corp. Quarterly |
| 2020-08-06 | 10Q | ELA/Envela Corp. Quarterly |
| 2020-05-12 | 10Q | ELA/Envela Corp. Quarterly |
| 2020-03-26 | 10K | ELA/Envela Corp. Annual |
Receive ELA News And Ratings
See the #1 stock for the next 7 days that we like better than ELA
ELA Financial Statistics
Sales & Book Value
| Annual Sales: | $180.4M |
|---|---|
| Cash Flow: | $2.2M |
| Price / Cash Flow: | 41 |
| Annual Sales: | $2.35 |
| Price / Book: | 5.55 |
Profitability
| EPS (TTM): | 0.39270 |
|---|---|
| Net Income (TTM): | $10.2M |
| Gross Margin: | $42.8M |
| Return on Equity: | 18.37% |
| Return on Assets: | 12.49% |
Envela Corp. Earnings Forecast
Key Envela Corp. Financial Ratios
-
The Gross Profit Margin over the past 36 years for ELA is 23.71%.
-
The Selling, General & Administrative Expenses for ELA have been equal to 19.18% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 6.62% of Operating Income.
-
The Net Earning history of ELA is 3.75% of Total Revenues.
-
Per Share Earnings over the last 36 years have been positive in 15 years.
Envela Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYAM |
|---|---|
| Industry: | Specialty Retail |
| Sector: | Consumer Discretionary |
| Current Symbol: | ELA |
| CUSIP: | 29402E |
| Website: | envela.com |
Debt
| Debt-to-Equity Ratio: | 0.38 |
|---|---|
| Current Ratio: | 5.19 |
| Quick Ratio: | 2.6 |
Price-to-Earnings
| Trailing P/E Ratio: | 50.6 |
|---|---|
| Forward P/E Ratio: | 0 |
ELA Technical Analysis vs Fundamental Analysis
Buy
96
Envela Corp. (ELA)
is a Buy
Is Envela Corp. a Buy or a Sell?
-
Envela Corp. stock is rated a BuyThe current Envela Corp. [ELA] share price is $13.06. The Score for ELA is 96, which is 92% above its historic median score of 50, and infers lower risk than normal.